Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial

Clinical trial NCT05590585 · COMPLETED

Trial details

NCT number: NCT05590585
Sponsor: Regeneron Pharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Moderate-to-Severe Atopic Dermatitis Atopic Eczema

Start date: 2023-01-11
Primary completion: 2024-11-14
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.